Search research articles
Contact Us
Filters
Showing results (11-20 of 140) with videos related to
Page
of 14
Sort By:
Journal of Neurochemistry
|
April 11, 2007
Use of proteomics for the identification of novel drug targets in brain diseases
Jose A Morón, Lakshmi A Devi
Drug and Alcohol Dependence
|
November 26, 2011
Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology
Steven D Stockton, Lakshmi A Devi
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 19, 2013
An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure
Steven D Stockton, Lakshmi A Devi
Pharmacology & Therapeutics
|
November 28, 2017
Orphan neuropeptides and receptors: Novel therapeutic targets
Lloyd D Fricker, Lakshmi A Devi
Frontiers in Pharmacology
|
May 26, 2015
Advancements in therapeutically targeting orphan GPCRs
Jennifer A Stockert, Lakshmi A Devi
Trends in Neurosciences
|
May 28, 2020
Post-translational Modifications of Opioid Receptors
Mariana Lemos Duarte, Lakshmi A Devi
Pharmacological Reviews
|
July 15, 2011
The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications
Lydia K Miller, Lakshmi A Devi
Current Opinion in Pharmacology
|
October 28, 2009
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin, Raphael Rozenfeld, Lakshmi A Devi
Methods in Enzymology
|
January 29, 2013
G-protein-coupled heteromers: regulation in disease
Ivone Gomes, Achla Gupta, Lakshmi A Devi
British Journal of Pharmacology
|
June 12, 2014
Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10
Wakako Fujita, Ivone Gomes, Lakshmi A Devi
Page
of 14
Search research articles
Search
Showing results (11-20 of 140) with videos related to
Sort By:
Page
of 14
Journal of Neurochemistry
|
April 11, 2007
Use of proteomics for the identification of novel drug targets in brain diseases
Jose A Morón, Lakshmi A Devi
Drug and Alcohol Dependence
|
November 26, 2011
Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology
Steven D Stockton, Lakshmi A Devi
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 19, 2013
An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure
Steven D Stockton, Lakshmi A Devi
Pharmacology & Therapeutics
|
November 28, 2017
Orphan neuropeptides and receptors: Novel therapeutic targets
Lloyd D Fricker, Lakshmi A Devi
Frontiers in Pharmacology
|
May 26, 2015
Advancements in therapeutically targeting orphan GPCRs
Jennifer A Stockert, Lakshmi A Devi
Trends in Neurosciences
|
May 28, 2020
Post-translational Modifications of Opioid Receptors
Mariana Lemos Duarte, Lakshmi A Devi
Pharmacological Reviews
|
July 15, 2011
The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications
Lydia K Miller, Lakshmi A Devi
Current Opinion in Pharmacology
|
October 28, 2009
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin, Raphael Rozenfeld, Lakshmi A Devi
Methods in Enzymology
|
January 29, 2013
G-protein-coupled heteromers: regulation in disease
Ivone Gomes, Achla Gupta, Lakshmi A Devi
British Journal of Pharmacology
|
June 12, 2014
Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10
Wakako Fujita, Ivone Gomes, Lakshmi A Devi
Page
of 14